Stryker Corporation SYK
- Market cap
- $103.9B
- P/E
- 28.0×
Follow SYK
Stryker Corporation (SYK) Price to free cash flow
As of 25 September 2026, Stryker Corporation (SYK) trades at a price to free cash flow of 22.2×. Over the past ten years it has ranged from 17.0× (November 2016) to 279× (October 2017); the current reading is higher than 6% of that period. That is in line with the Medical Devices industry median of 22.5× and above the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 31.4× | (20.27%) |
| FY2024 | 39.3× | 9.71% |
| FY2023 | 35.9× | (21.54%) |
| FY2022 | 45.7× | 24.12% |
| FY2021 | 36.8× | 11.65% |
| FY2020 | 33.0× | (35.23%) |
| FY2019 | 50.9× | 76.97% |
| FY2018 | 28.8× | (53.18%) |
| FY2017 | 61.5× | 95.99% |
| FY2016 | 31.4× | (36.31%) |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 25.7× | (6.71%) |
| Mar 2026 | 27.5× | (12.24%) |
| Dec 2025 | 31.4× | (5.97%) |
| Sep 2025 | 33.4× | (11.23%) |
| 42 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| PHG Koninklijke Philips N.V. compare | 12.9× |
| BSX Boston Scientific Corporation compare | 17.8× |
| MDT Medtronic PLC compare | 18.5× |
| GEHC GE HealthCare Technologies Inc. compare | 19.1× |
| STE STERIS plc compare | 21.8× |
| SYK Stryker Corporation | 22.2× |
| ABT Abbott Laboratories compare | 22.5× |
| DXCM DexCom, Inc. compare | 23.6× |
| EW Edwards Lifesciences Corporation compare | 35.4× |
| Medical Devices industry median | 22.5× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on SYK
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement